share_log

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga ·  Aug 30, 2023 21:06

Gainers

  • NanoVibronix (NASDAQ:NAOV) stock increased by 71.0% to $2.48 during Wednesday's pre-market session. The company's market cap stands at $4.1 million.
  • Aravive (NASDAQ:ARAV) stock moved upwards by 21.13% to $0.14. The market value of their outstanding shares is at $10.6 million.
  • Dermata Therapeutics (NASDAQ:DRMA) stock increased by 18.81% to $1.2. The company's market cap stands at $3.8 million.
  • AEON Biopharma (AMEX:AEON) stock rose 14.17% to $4.59. The company's market cap stands at $170.5 million.
  • Akso Health Group (NASDAQ:AHG) shares increased by 12.01% to $0.82. The company's market cap stands at $18.6 million.
  • Harvard Bioscience (NASDAQ:HBIO) stock moved upwards by 11.96% to $4.96. The company's market cap stands at $211.7 million.

Losers

  • Outlook Therapeutics (NASDAQ:OTLK) stock decreased by 78.3% to $0.31 during Wednesday's pre-market session. The company's market cap stands at $79.5 million.
  • FibroGen (NASDAQ:FGEN) stock declined by 24.61% to $0.96. The market value of their outstanding shares is at $94.7 million.
  • OKYO Pharma (NASDAQ:OKYO) stock decreased by 12.83% to $2.65. The market value of their outstanding shares is at $67.7 million.
  • Tivic Health Systems (NASDAQ:TIVC) shares declined by 11.75% to $2.63. The company's market cap stands at $3.8 million.
  • LENSAR (NASDAQ:LNSR) stock declined by 11.72% to $3.09. The market value of their outstanding shares is at $34.7 million.
  • Acorda Therapeutics (NASDAQ:ACOR) stock decreased by 11.64% to $11.24. The company's market cap stands at $13.9 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment